Produkty 93395-31-4

CAS 93395-31-4 występuje w naszej ofercie pod nazwami: 8β–(2–Hydroxy–2–methyl –3–oxobutyryloxy)glucozaluzanin C, (2R)-2-Hydroxy-2-methyl-3-oxobutanoic acid (3aR,4R,6aR,8S,9aR,9Br)-8-(beta-D-glucopyranosyloxy)dodecahydro-3,6,9-tris(methylene)-2-o xoazuleno(4,5-b)furan-4-yl ester, 8beta-(2-Hydroxy-2-methyl-3-oxobutyryloxy)glucozaluzanin C. Oferty producentów: GLPBio, Biosynth, MedChemExpress. Dostępne opakowania: 5mg, 10mg, 25mg, 50mg, Get quote.

8β–(2–Hydroxy–2–methyl –3–oxobutyryloxy)glucozaluzanin C
GLPBio
  • opakowanie: 5mg
  • Warianty: 1
od 2932,61
Zobacz produkt
(2R)-2-Hydroxy-2-methyl-3-oxobutanoic acid (3aR,4R,6aR,8S,9aR,9Br)-8-(beta-D-glucopyranosyloxy)dodecahydro-3,6,9-tris(methylene)-2-o xoazuleno(4,5-b)furan-4-yl ester
Biosynth
  • opakowanie: 10mg, 5mg, 25mg, 50mg
  • Warianty: 4
Zobacz produkt
8beta-(2-Hydroxy-2-methyl-3-oxobutyryloxy)glucozaluzanin C
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[3,6,9-trimethylidene-2-oxo-8-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-4-yl] 2-hydroxy-2-methyl-3-oxobutanoate (CAS 93395-31-4) to związek chemiczny o wzorze sumarycznym C26H34O12 i masie molowej 538.5 g/mol. Nazwa systematyczna IUPAC: [3,6,9-trimethylidene-2-oxo-8-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-4-yl] 2-hydroxy-2-methyl-3-oxobutanoate. InChIKey: ZFRBQIGYWHKJRW-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC26H34O12
Masa molowa538.5 g/mol
Nazwa IUPAC[3,6,9-trimethylidene-2-oxo-8-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-4-yl] 2-hydroxy-2-methyl-3-oxobutanoate
InChIKeyZFRBQIGYWHKJRW-UHFFFAOYSA-N
SMILESCC(=O)C(C)(C(=O)OC1CC(=C)C2CC(C(=C)C2C3C1C(=C)C(=O)O3)OC4C(C(C(C(O4)CO)O)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 8beta-(2-Hydroxy-2-methyl-3-oxobutyryloxy)glucozaluzanin C, orb1683268
Izomery (ten sam wzór sumaryczny)
methyl (2S,3S,4aR,6R,8R,8aS)-8-[(E)-3-(4-acetyloxy-3-methoxyphenyl)prop-2-enoyl]oxy-6-hydroxy-2,3-dimethoxy-2,3-dimethyl-5,7,8,8a-tetrahydro-4aH-benzo[b][1,4]dioxine-6-carboxylate C26H34O12
(2S,3R,4S,5S,6R)-2-[4-[[(3S,4R,5S)-3-hydroxy-5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)oxolan-3-yl]methyl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol C26H34O12
(2S,3R,4S,5S,6R)-2-[4-[(3R,4S)-4-hydroxy-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol C26H34O12
(2R,3R,4S,5S,6R)-2-[(4-hydroxy-3-methoxyphenyl)-[(3S,4R,5S)-5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)oxolan-3-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol C26H34O12
(2R,3R,4S,5S,6R)-2-[[(1S,2S,3S)-3,7-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-6-methoxy-2,4-dihydro-1H-naphthalen-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol C26H34O12
(2S,3R,4S,5S,6R)-2-[4-[(1R,2S)-1,3-dihydroxy-2-[4-[(E)-3-hydroxyprop-1-enyl]-2-methoxyphenoxy]propyl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol C26H34O12